Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
A Phase 2 study evaluating Simtuzumab (GS-6624) for idiopathic pulmonary fibrosis was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: 68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis [EARLY_Phase 1]
This document updates on a Phase 1 trial evaluating 68Ga-BMV101 PET/CT in patients with Idiopathic Pulmonary Fibrosis.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
A Phase 2 long-term safety study of GS-6624 in adults with idiopathic pulmonary fibrosis has been terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
Open-label long-term safety study of pirfenidone in idiopathic pulmonary fibrosis; results from a Phase 3 trial have been posted.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis [NA]
This entry reports on the completion of a clinical trial investigating pulmonary rehabilitation for idiopathic pulmonary fibrosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 trial update on tolerability of a single dose of gefapixant (AF-219/MK-7264) in idiopathic pulmonary fibrosis completed with results…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174) [Phase 2]
A Phase 2 safety and pharmacokinetics study of nintedanib (BIBF 1120) in Japanese patients with idiopathic pulmonary fibrosis; results have …
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)
An update on a clinical trial examining progression of mild to moderate idiopathic pulmonary fibrosis in patients treated with pirfenidone (…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: The Occurence of Inflammation and Oxidative Stress in Lung Diseases
A completed clinical trial evaluated the occurrence of inflammation and oxidative stress in multiple lung diseases. The conditions studied i…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: D2212C00002 J-Phase II Study [Phase 2]
AstraZeneca's Phase II J-Phase study D2212C00002 for idiopathic pulmonary fibrosis has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis
This clinical trial update reports that a study evaluating the effect of pirfenidone on cough in idiopathic pulmonary fibrosis has completed…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. [Phase 2]
Phase 2 study of inhaled GeNOsyl for pulmonary arterial hypertension and pulmonary hypertension due to idiopathic pulmonary fibrosis has com…
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension [Phase 2]
Phase 2 trial evaluating sildenafil to increase exercise capacity in idiopathic pulmonary fibrosis with pulmonary hypertension has completed…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
This clinical trial update covers idiopathic pulmonary fibrosis, focusing on pathogenesis and staging within the SCOR framework for occupati…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Exhaled Breath Condensate Biomarkers and Cough in IPF
This update summarizes findings from a completed trial investigating exhaled breath condensate biomarkers and cough in idiopathic pulmonary …
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 study evaluating the safety and tolerability of combining N-acetylcysteine with pirfenidone in idiopathic pulmonary fibrosis; the tr…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 safety study of oral pirfenidone in patients with idiopathic pulmonary fibrosis and pulmonary fibrosis has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 1, Phase 2]
This update notes that a Phase 1/Phase 2 study evaluating different doses of SAR156597 in Idiopathic Pulmonary Fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis [Phase 1]
Phase 1 clinical trial evaluating mesenchymal stem cells for idiopathic pulmonary fibrosis; trial completed and results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
A Phase 2 study evaluated the safety and effectiveness of CNTO 888 administered intravenously in participants with idiopathic pulmonary fibr…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]
This clinical trial update reports the completion of Phase 2 testing of zileuton for idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Microaspiration in Pulmonary Fibrosis
The UCSF-sponsored clinical trial on microaspiration in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-27Clinical Trial Update: Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis
Completed clinical trial update evaluating the reliability of the 4-metre gait speed test in idiopathic pulmonary fibrosis patients.
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF) [NA]
A completed clinical trial update examines the daytime use of the Oxymizer oxygen-conserving device in patients with idiopathic pulmonary fi…
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis [Phase 1]
A Phase 1 study evaluating safety and efficacy of GS-6624 (formerly AB0024) in idiopathic pulmonary fibrosis has completed. The trial sponso…